Cargando…
The immunotherapeutic role of indoleamine 2,3‐dioxygenase in head and neck squamous cell carcinoma: A systematic review
BACKGROUND: Novel cancer immunotherapy seeks to harness the body's own immune system and tip the balance in favour of antitumour activity. The intracellular enzyme indoleamine 2,3‐dioxygenase (IDO) is a critical regulator of the tumour microenvironment (TME) via tryptophan metabolism. The poten...
Autores principales: | Lin, Daniel J., Ng, James C. K., Huang, Lei, Robinson, Max, O’Hara, James, Wilson, Janet A., Mellor, Andrew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600953/ https://www.ncbi.nlm.nih.gov/pubmed/34053179 http://dx.doi.org/10.1111/coa.13794 |
Ejemplares similares
-
Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
por: Farooq, Asim, et al.
Publicado: (2023) -
Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
por: Mellor, Andrew L., et al.
Publicado: (2017) -
Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
por: Asghar, Kashif, et al.
Publicado: (2017) -
Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020) -
Meta-analysis: the diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy
por: Torlot, F J, et al.
Publicado: (2013)